The main thing in the last week is litigation regarding mandatory licenses, new fines for patent violations and the expansion of drug coverage. In addition, the focus is on the HPV vaccine, legislative initiatives and the upcoming update of drug lists. Major events in the weekly summary The Supreme Court supported the extension of the compulsory license for Kodkod's patents for the distribution of the drug Trilexa for cystic fibrosis for the entire period of validity of the exclusive rights. The State Duma committee recommended rejecting the bill to introduce pre-registration consultations for drug developers. The President of Russia ordered to include an HPV vaccine in the national calendar of preventive vaccinations using the local vaccine. The Russian Ministry of Health has proposed expanding the free drug program for patients with severe dyslipidemia, providing additional funding in the amount of 1.6 billion rubles per year. The court refused to grant Grophram a compulsory license to MSD's patents for the production of an analogue of the drug Zeptir for hepatitis C. Roszdravnadzor recorded an increase in the number of requests regarding the unavailability of preferred drugs by 11% during the nine months of 2026. The State Duma rejected the bill that establishes waiting periods for high-tech medical treatment. The Russian Ministry of Economic Development proposed to introduce turnover fines of up to 200% of revenues for infringement of patent rights in the circulation of medicines. The Russian Ministry of Health has scheduled a meeting of the Committee for Formulating Drug Lists for November 10, which will consider three drugs for the treatment of hemophilia A and HIV infection. More details - in the full version of the summary on our channel in Max.

The main thing in the last week is litigation regarding mandatory licenses, new fines for patent violations and the expansion of drug coverage. In addition, the focus is on the HPV vaccine, legislative initiatives and the upcoming update of drug lists. Major events in the weekly summary The Supreme Court supported the extension of the compulsory license for Kodkod's patents for the distribution of the drug Trilexa for cystic fibrosis for the entire period of validity of the exclusive rights. The State Duma committee recommended rejecting the bill to introduce pre-registration consultations for drug developers. The President of Russia ordered to include an HPV vaccine in the national calendar of preventive vaccinations using the local vaccine. The Russian Ministry of Health has proposed expanding the free drug program for patients with severe dyslipidemia, providing additional funding in the amount of 1.6 billion rubles per year. The court refused to grant Grophram a compulsory license to MSD's patents for the production of an analogue of the drug Zeptir for hepatitis C. Roszdravnadzor recorded an increase in the number of requests regarding the unavailability of preferred drugs by 11% during the nine months of 2026. The State Duma rejected the bill that establishes waiting periods for high-tech medical treatment. The Russian Ministry of Economic Development proposed to introduce turnover fines of up to 200% of revenues for infringement of patent rights in the circulation of medicines. The Russian Ministry of Health has scheduled a meeting of the Committee for Formulating Drug Lists for November 10, which will consider three drugs for the treatment of hemophilia A and HIV infection. More details - in the full version of the summary on our channel in Max.